Search for: "Pharma, Inc"
Results 61 - 80
of 1,854
Sort by Relevance
|
Sort by Date
14 Feb 2023, 12:29 pm
</span> </p> <p> <span style="display: initial;"> <br/> </span> </p> <p> <span style="display: initial;"> <span style="display: initial;"> Famous trademark infringement </span> </span> <a href="https://www.business.com/articles/5-trademark-cases-and-what-you-should-learn-from-them/"… [read post]
10 Feb 2023, 1:10 pm
Pure Hemp Collective Inc., Docket No. 22-01363 (Fed. [read post]
4 Feb 2023, 5:26 pm
In re Caremark Int’l Inc. [read post]
20 Jan 2023, 2:21 pm
(credit: CSPAN) Infamous ex-pharmaceutical executive Martin Shkreli is yet again in trouble with the Federal Trade Commission, which announced today that the convicted fraudster has failed to cooperate with the commission's investigation into whether he violated his lifetime ban from the pharmaceutical industry by starting a company last year called "Druglike, Inc. [read post]
12 Jan 2023, 12:00 am
Newman Ferrara LLP Announces Corporate Governance Investigations of Zentalis Pharmaceuticals, Inc. [read post]
22 Dec 2022, 7:59 am
Kite Pharma, Inc., No. 21-1566. [read post]
13 Dec 2022, 7:41 pm
Duane Morris LLP Caterpillar Inc. [read post]
6 Dec 2022, 4:50 pm
Astellas Pharma US, Inc., Circuit Court of Cook County, Illinois County Dept., Chancery Div., 2019 CH 14483 (Nov. 28, 2022). [read post]
8 Nov 2022, 1:56 pm
Kite Pharma, Inc. [read post]
8 Nov 2022, 1:56 pm
Kite Pharma, Inc. [read post]
2 Nov 2022, 11:43 am
Hetronic International, Inc. [read post]
1 Nov 2022, 11:20 am
-based Merck & Co Inc for anti-competitive behaviour in a case brought by Spanish rival Insud Pharma over a contraception device. [read post]
31 Oct 2022, 3:54 pm
., Inc. v. [read post]
26 Oct 2022, 7:59 am
., Inc. v. [read post]
14 Oct 2022, 6:05 am
” “CVS, Walgreens and Walmart Inc. characterize the purported conflict of interest as a form of irreparable harm, which is one of several factors Judge Polster would weigh when considering whether to stay the appointment. [read post]
13 Oct 2022, 6:28 am
., Inc. v. [read post]
4 Oct 2022, 1:10 pm
Kite Pharma, Inc. concerns the test for determining whether the “written description of [an] invention” is so inadequate as to render a patent invalid. [read post]
26 Sep 2022, 4:49 am
Kite Pharma, Inc., No. 21-1566 According to the Federal Circuit, US patent law contains separate and distinct written description and enablement requirements. [read post]
22 Sep 2022, 9:54 am
AbbVie Inc, 7th U.S. [read post]
13 Sep 2022, 2:16 am
” Eurofins Pharma US Holdings v. [read post]
